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Abstract
Purpose The purpose of this study was to assess the differ-
ences in cooling behavior between the first-generation
cryoballoon (CB-1G) and the second-generation cryoballoon
(CB-2G) quantitatively to understand the freezing capabilities
and to benefit from the improved efficacy of the CB-2G in
patients with atrial fibrillation.
Methods We analyzed quantitatively the ice formation of the
CB-1G and CB-2G catheters in vitro in a 37 °C warm water
bath during freezing for 60, 120, 180, 240, and 300 s,
respectively.
Results The mean-covered surface area and the relative cov-
erage of the ice spots on the CB-2G were significantly differ-
ent from the spots on the CB-1G for the 28-mm CBs but not
for the 23-mmCBs.Whereas for the CB-1G, the ice formation
was discontiguous with four isolated ice spots; the CB-2G
showed a contiguous ice cap covering the entire distal part
including the pole of the balloon. No homogeneous cooling
behavior could be observed at the equatorial level with both
catheters. Temporal differences on the ice formation could be
observed for the 28-mm CB-2G but not for the 23-mm CB-
2G.
Conclusion The new-generation CB-2G showed more pow-
erful and homogeneous cooling behavior, especially for the
28-mm CB. Whether this translates into higher long-term
success rates is currently unknown. The impact of the more
effective cooling and the longer dissolving duration of the ice
cap of the new-generation CB-2G on procedural safety needs
to be investigated.
Keywords Cryoballoon technology . Pulmonary vein
isolation . Atrial fibrillation
1 Introduction
Cryoballoon (CB) ablation catheters are increasingly used as
an alternative to point-by-point ablation using radiofrequency
energy for pulmonary vein isolation (PVI) for the treatment of
atrial fibrillation. Despite being engineered as a simple device
to create a complete circumferential lesion around the pulmo-
nary veins with only a limited number of applications, the
first-generation cryoballoon (Artic Front, Medtronic, MN,
USA) showed heterogeneous cooling behavior resulting in
nonuniform temperature distribution on the CB surface [1].
Several anatomical predictors for the acute and mid-term
failure of PVI have been identified that can at least in part be
explained by this cooling pattern. Recently, a second-
generation CB (Arctic Front Advance) has been approved
for PVI in the USA, Canada, and Europe. The constructional
changes of the second-generation CB aim to address this
limitation and to improve acute PVI success rates, success
rates in more challenging anatomical variants, and potentially
the permanency of PVI after CB ablation [2]. The impact of
these changes on clinical outcome and safety is currently
unclear. First results from two animal studies and one human
study demonstrated improved acute efficacy [3–5], but critical
comments regarding the current recommendations for the use
of the cryoballoon have been published [6]. To be able to
benefit from its improved efficacy without impairing the
safety of the procedure, the freezing capabilities of the CB
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have to be understood. Currently, however, only qualitative
descriptions and sketches of the potential cooling behavior of
this new device exist [5, 7].
The purpose of this study was to assess the differences in
cooling behavior between the first-generation cryoballoon
(CB-1G) and the second-generation cryoballoon (CB-2G)
quantitatively.
2 Methods
Freezing cycles using the first generation (CB-1G) and second
generation (CB-2G) were performed in a static 37 °C warm
water bath showing an almost identical freezing parameter
than blood. To compare the freezing behavior of the common-
ly used application duration of 300 s for the CB-1G and 240 s
for the CB-2G catheters, we performed three freezes for each
of the three 23-mm CB and of the three 28-mm CB of both
generations. To investigate the time dependency of the cooling
behavior of the CB-2G, we performed freezing cycles of 60,
120, 180, and 240 s for three 23-mm CBs and three 28-mm
CBs, respectively.
For better visualization of the ice cap for subsequent quan-
tification, blue dye was added to the water. After completing
the freezing cycle, the CB was removed from the water bath,
photographed immediately in two views, and re-submerged
into the water bath to measure the time until deflation. The
pictures of the CB catheters with the resulting ice caps were
analyzed using a visualization application (ParaView 3.12.0)
and quantified with the implemented ruler. Maximal thickness
and the diameter of the ice caps of the CB-1G and the
thickness of the ice cap at the pole and the minimal and
maximal ice coverage of the CB-2G were measured (Fig. 1).
Absolute and relative coverage of the ice cap were calculated
for the entire balloon surface. The maximum diameter of a
pulmonary vein than can theoretically be isolated based on the
ice formation was measured for the above-described data
(Fig. 2). For in vivo comparison, data from 53 freezing cycles
using an arbitrary sample of consecutive patients, 3
treated with the CB-1G and 3 treated with the CB-2G,
was analyzed.
3 Statistical analysis
Continuous variables are presented as mean plus or minus
standard deviation (±SD). Comparisons were made using
Student’s t test or one-way ANOVA using Tukey post hoc
tests (p=0.05). A two-tailed p value <0.05 was considered
statistically significant. Analysis was performed using SPSS
21.0 (SPSS Inc., Chicago, USA).
4 Results
4.1 In vitro behavior of CB-1G
For the 23- and 28-mmCB-1G, the mean thickness and mean-
covered surface area of the ice spots were 2.8±0.4 and 3.2±
0.4 mm and 740±153 and 430±182 mm2, respectively
(Table 1). This resulted in a mean relative coverage of the
entire surface of 52±10 and 17±7 %, respectively, after a
freezing duration of 300 s. In all tests, the ice distribution on
the surface was not homogenous with four separated ice spots
as shown in the example in Fig. 1. In only one of the 23-mm
CB, ice formation could be observed at the pole of the CB.
Minimal temperature of the freezes performed in vitro was
−63±2 and −47±2 °C for the 23- and 28-mm CB, respective-
ly. Mean time till deflation of the 23- and 28-mm CB at 20 °C
was 76±42 and 44±15 s, respectively.
4.2 In vitro behavior of the CB-2G
For a freezing duration of 240 s, the CB-2G showed a com-
plete ice cap covering the distal part of the balloon in 100% of
the tests for both CB diameters. The minimal temperature of
the freezing cycles for the 23- and 28-mm CB in the water
bath was −52±2 and −47±2 °C, respectively, with a mean
Fig. 1 Measurements performed on the ice caps of a first-generation (a)
(CB-1G) 28-mm CB and a second-generation (b) (CB-2G) 28-mm CB.
The blue area in a represents the optimally cooled area assuming rotation
of the balloon between subsequent freezes. diam diameter of the ice spot,
hmin minimal ice coverage, hmax maximal ice coverage
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thickness of the ice cap at the pole of 2.9±0.6 and 3.0±
0.6 mm, respectively (Table 1). This thickness was compara-
ble to the CB-1G (Table 1). The area of the homogeneously
covered ice cap of the 23-mmCB-2Gwas similar to the one of
the 23-mmCB-1G, resulting in a mean relative coverage of 42
±4 and 52±10%, respectively (p=0.119). For the 28-mmCB,
the area of the homogeneously covered ice cap of the CB-2G
was significantly larger (p=0.016) compared to the area of the
CB-1G resulting in a mean relative coverage of 27±8 and 17±
7 % (p=0.007), respectively.
Neither for the 23-mmCB-2G nor for the 28-mmCB-2G, a
complete ice cap could be observed at the equatorial level of
the CB-2G, reflected by a minimal length of the ice cap (hmin)
of 8.1±0.6 mm (23-mm CB) and 7.7±2.2 mm (28-mm CB),
which is smaller than half the balloon size. This transfers into
a maximal diameter of the CB with homogeneous cooling of
25.4±1.0 mm for the 28-mm CB-2G and of 21.8±1.1 mm for
the 23-mm CB-2G (Table 1). At the level of the equator of the
balloon, a typical sinusoidal pattern of the ice cap could be
observed in eight of nine tests for the 23-mmCB (89%) and in
seven of nine tests for the 28-mm CB (78 %). In the three
freezing cycles, an asymmetrical ice cap could be observed,
most likely due to a partially occluded refrigerant nozzle.
For the four different freezing durations, the maximal
thickness of the ice cap, the absolute and the relative area of
the homogeneously covered ice cap, and the maximal diam-
eter of the homogeneously cooled surface were significantly
different for the 28-mm CB (p<0.001) but not for the 23-mm
CB (Table 2). Post hoc analysis revealed that the diameter and
the homogeneously covered surface area and the ice-covered
surface area were not significantly different between freezes
with a duration of 240 and 180 s and between 60 and 120 s for
the 28-mm CB.
4.3 Clinical in vivo data
Minimal CB temperature of three consecutive patients treated
with the CB-1G and the three patients treated with the CB-2G
catheter (overall 27 and 26 freezing cycles, respectively) was
−43±7 and −45±9 °C, respectively, and time to deflation was
27±13 and 49±19 s (p<0.001) (Table 3). The power to detect
a difference of 15 s between the two CBs in the in vivo dataset
with a mean duration of 27 s for the CB-1G and a SD of 20 s
was 0.97.
5 Discussion
In April 2012, Medtronic received a Premarket Approval
(PMA) from the Food and Drug Administration (FDA) for
Table 1 Summary of the in vitro data after a freezing duration of 300 s for the CB-1G and 240 s for the CB-2G
23-mm CB 28-mm CB
CB-1G CB-2G p value CB-1G CB-2G p value
Temperature [°C] −63±2 −52±2 <0.001 −47±2 −47±2 0.629
Time to deflation [s] 76±42 95±5 0.471 44±15 100±34 <0.001
Max. Thickness [mm] 2.8±0.4 2.9±0.6 0.800 3.2±0.4 3.0±0.6 0.497
Absolute area [mm2] 740±153 585±42 0.151 430±182 690±197 0.016
Relative area [%] 52±10 42±4 0.119 17±7 27±8 0.007
Min. length hmin [mm] n.a. 8.1±0.6 n.a. n.a. 7.7±2.2 n.a.
Max. length hmax [mm] n.a. 14.1±1.9 n.a. n.a. 16.5±2.1 n.a.
Max. diameter [mm] n.a. 21.7±1.1 n.a. n.a. 25.4±1.0 n.a.
n.a. not available
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Fig. 2 Cryoballoon with the ice caps visualized in a pulmonary vein. The
equators of the cryoballoons are highlighted by the dashed line. a The
blue area represents the critical balloon surface that can be covered by
rotation of the CB-1G. bMeasurement of themaximal diameter of the PV
that can be treated with CB-2G without rotation, determined by hmin
“catheter changes to increase the uniformity of the distal
balloon surface temperature (increased number of refrigerant
ports on the injection tube coil, more distal position of the
injection tube, increased refrigerant flow on the 28 mm bal-
loon), to add new visual marker on the catheter shaft and to
implement additional minor changes to the design and label-
ing” [8]. The reason for submitting the supplement
(Supplement Number S015 to PMA number P 100010) was
classified as “Design Change—Minor”. In the present study,
we quantified the effect of these constructional changes of the
second-generation cryoballoon (CB-2G) compared to the
first-generation cryoballoon (CB-1G) on the cooling behavior
in vitro.
In contrast to the first-generation CB, a significantly larger
ice formation with a homogeneous ice distribution pattern and
consecutively a longer thawing period with a prolonged time
to deflation can be observed after the recommended freezing
duration of 240 s with the CB-2G. Especially in the pole
region of the CB-2G, there is complete coverage of the bal-
loon surface. Therefore, homogeneous cooling can be expect-
ed in vivo in the entire distal one third of the CB. However, no
homogeneous cooling can be observed at the equatorial level
of the CB-2G, and there were three cases of atypical ice cap
formation, possibly due to occlusion of the refrigerant nozzle.
The technical changes of the CB-2G resulted in significant
changes of the investigated parameters compared to the CB-
1G mainly for the 28-mm CB. This might be explained by the
increased refrigerant flow coming along with the second gen-
eration of the 28-mm CB and the greater benefit of the
doubling of the number of refrigerant jets on the approximate-
ly 50 % bigger surface area compared to the 23-mm CB. For
the 23-mm CB of the first generation, the surface was already
nicely covered by the four refrigerant jets, resulting in a
similar surface area than with the eight jets of the second-
generation balloon.
5.1 Potential clinical implications
The increase of the number of refrigerant jets from four to
eight, the more distal positioning of the refrigerant injection
coil, and an increase of the fluid flow to compensate for the
increased injection area resulted in a homogeneously covered
distal part of the CB-2G in all tests. Except for the 3 out of the
18 freezing cycles with asymmetrical freezing pattern, a typ-
ical sinusoidal pattern of the ice cap at the equatorial plane can
be observed (Fig. 1). In none of the cases, a complete ice cap
could be observed at the equatorial level of the CB-A.
Recently, we published anatomical predictors for PVI fail-
ure using the first-generation cryoballoon [1]. A sharp carina
or a sharp ridge between the left superior pulmonary vein and
the left atrial appendage was identified as a predictor for acute
failure of PVI in a multivariate analysis. These obstacles may
be overcome by the CB-2G. The more homogeneous cooling
over the distal one third of the CB-A can be expected to result
in a higher acute success rate for PVI even for small veins
using the 28-mm cryoballoon and other challenging
Table 2 Time-dependent parameter for the 23- and 28-mm CB-2G
23-mm CB-2G 28-mm CB-2G
Duration [s] Thickness [mm] Area [mm2] Diameter [mm] Thickness [mm] Area [mm2] Diameter [mm]
60 2.2±0.2 421±26 20.0±0.5 1.7±0.3 436±27 22.2±1.1
120 2.3±0.2 472±15 20.8±0.7 2.2±0.3 517±102 23.5±1.9
180 2.3±0.1 497±23 21.2±0.2 2.4±0.2 619±96 24.3±1.0
240 2.8±0.5 585±42 21.8±1.1 3.0±0.4 725±84 25.4±1.0
p 0.102 0.001 0.096 <0.001 <0.001 <0.001
Diameter max. diameter with homogeneous ice coverage
Table 3 Summary of the in vivo data
CB-1G CB-2G P
Temperature [°C] −43±7 −45±9 0.377
Time to deflation [s] 27±13 49±19 <0.001
CB-1G first-generation cryoballoon, CB-2G second-generation
cryoballoon
Fig. 3 Inferior view of a left atrium with the old-generation CB visual-
ized in the right inferior PV. The blue area represents the coldest area. The
arrows indicate regions with suboptimal contact with lower cryoballoon
temperature. The white arrow indicates the region where improvement of
freezing can be expected with the second-generation CB
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anatomical variations. This is reflected in the early clinical
experience with the CB-A reported by Fürnkranz et al. who
showed a significantly higher single-shot PVI rate of 84 %
with the CB-2G compared to 51 % with the CB-1G [5].
Furthermore, the technical changes of the CB-2G may allow
for successful PVI with less precise alignment of the catheter
(Fig. 3). Due to a reduced and less homogeneous cooling
behavior at the equator of the CB-2G, a rotation or positional
change of the balloon catheter might still be needed in certain
situations in order to achieve a continuous circumferential
lesion. For a freezing cycle with optimal heat transfer, utilizing
the homogeneously cooled distal one third of the balloon, the
PV diameter should be smaller than 21 and 25 mm with an
axially oriented 23- and 28-mm cryoballoon, respectively,
based on the homogeneous cooling of the tip (Fig. 2). If larger
veins are targeted or the orientation of the CB is not aligned
with the PV axis, equatorial contact with reduced and less
homogeneous cooling behavior results in suboptimal heat
transfer, but this might still be sufficient to achieve isolation
in a majority of PVs.
Temporal analysis of the freezing behavior revealed for the
28-mm CB-2G, a similar cooling behavior after 240 and 180 s
in terms of the surface area and the maximal diameter of the
CB with homogenous cooling. Consequently, by reducing the
freezing duration from 240 to 180 s, no difference regarding
the alignment of the catheter for optimal heat transfer might be
observed, whereas for a shorter freezing duration, the CB
alignment might become more important again. For the 23-
mm CB-2G, these might be negligible, and the parameter
primarily influencing the efficacy of the cryoballoon applica-
tion is the freezing duration itself. Whether the improved
cooling has as well an impact on prediction of phrenic nerve
palsy [9] and other safety concerns needs further
investigation.
6 Limitations
Freezing cycles were performed in vitro in a water bath with
37 °C without any surface contact to the myocardium and
fluid flow which might result in absolute temperature differ-
ences and ice volumes. Our results, however, reflect the dif-
ferences of the two CB generations, which can be expected to
be similar under same conditions in vivo and in vitro.
7 Conclusions
The new-generation CB-2G showed more powerful and ho-
mogeneous cooling behavior, especially at the pole of the
balloon. Whether this translates into higher long-term success
rates is currently unknown. The impact of the more effective
cooling and the longer dissolving duration of the ice cap of the
new-generation CB-2G on procedural safety needs to be
investigated.
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